Publications by authors named "Josefine Bostner"

Claim this Profile
R
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
Josefine Bostner, Anya Alayev, Adi Y Berman, Tommy Fornander, Bo Nordenskjöld

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
Elin Karlsson, Ivana Magić, Josefine Bostner, Christine Dyrager, Fredrik Lysholm

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.
Subrata Manna, Josefine Bostner, Yang Sun, Lance D Miller, Anya Alayev

Clin Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts.
Josefine Bostner, Elin Karlsson, Cecilia Bivik Eding, Gizeh Perez-Tenorio, Hanna Franzén

Endocr Relat Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
Elin Karlsson, Gizeh Pérez-Tenorio, Risul Amin, Josefine Bostner, Lambert Skoog

Breast Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VAV3 mediates resistance to breast cancer endocrine therapy.
Helena Aguilar, Ander Urruticoechea, Pasi Halonen, Kazuma Kiyotani, Taisei Mushiroda, Josefine Bostner

Breast Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit.
Josefine Bostner, Elin Karlsson, Muneeswaran J Pandiyan, Hanna Westman, Lambert Skoog

Breast Cancer Res Treat· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
Elin Karlsson, Marie Ahnström Waltersson, Josefine Bostner, Gizeh Pérez-Tenorio, Birgit Olsson

Genes Chromosomes Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer.
Josefine Bostner, Lambert Skoog, Tommy Fornander, Bo Nordenskjöld, Olle Stål

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis